Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure
- 31 July 2005
- journal article
- clinical trial
- Published by Elsevier BV in Lung Cancer
- Vol. 49 (1), 95-108
- https://doi.org/10.1016/j.lungcan.2004.11.024
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancerLung Cancer, 2003
- Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial ct scan-based studyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinomaCancer, 2001
- Combined modality treatment using concurrent radiotherapy and pharmacologically-guided carboplatin for inoperable and incompletely resected non-small cell lung cancerLung Cancer, 2001
- Radiation effects on the lung: clinical features, pathology, and imaging findings.American Journal of Roentgenology, 1992
- Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteriaInvestigational New Drugs, 1992
- Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.Radiology, 1992
- The New International Staging System for Lung CancerSurgical Clinics of North America, 1987
- Radiation fibrosis mimicking local recurrence in small cell carcinoma of the bronchusThe British Journal of Radiology, 1984